<DOC>
	<DOCNO>NCT01351961</DOCNO>
	<brief_summary>In cross sectional study `` Adelahyde 1 '' take place 2001 2005 , investigator data suggest vascular alteration may play role set subjective memory complaint . This longitudinal study ( Adelahyde 2 ) aim confirm role vascular factor evolution cognitive function dementia .</brief_summary>
	<brief_title>Vascular Alteration Evolution Cognitive Impairment</brief_title>
	<detailed_description>Background : The role arterial hypertension vascular alteration development cognitive decline major issue research clinical practice . In recently publish cross-sectional study ( Kearney-Schwartz , Rossignol et al . 2009 ) , conduct `` ADELAHYDE '' cohort comprise old hypertensive patient memory complaint , investigator show association arterial change ( hypertrophy arterial stiffness , endothelial dysfunction ) cognitive function and/or white matter hyperintensities MRI . A longitudinal study mean confirm role vascular factor evolution cognitive function onset dementia . Objectives : ) Primary : To establish , `` ADELAHYDE '' cohort , relationship vascular alteration assess baseline cross-sectional study ( hypertrophy arterial stiffness , endothelial dysfunction ) evolution cognitive function ( primary study endpoint ) 8-year follow-up period ; ii ) Secondary ) To investigate evolution white matter hyperintensities MRI ( secondary study endpoint ) function peripheral vascular status , especially endothelial function . b ) Determine role genetic factor biomarkers oxidative stress ( DNA serum biobanks collect first visit ) evolution cognitive function white matter hyperintensities . Methods : Prospective longitudinal single center study . All patient ( 378 subject ) participate baseline cross-sectional study conduct 2001 2005 , reconvene Clinical Investigation Centre ( CIC ) Nancy . As cross-sectional study , follow assessed longitudinal phase : pulse wave velocity ( PWV ) , carotid ultrasonography , flow-mediated dilation , brain MRI semi-quantification white matter hyperintensities , cognitive function evaluation measurement various biomarkers endothelial function . Expected fallout : A major benefit project cohort already explore term cognitive function , arterial property neurovascular imaging ( MRI ) . Thus , program reconvene subject project 2011 enable u identify role vascular alteration evolution cognitive function leucoaraiosis population high risk dementia period least 8 year . Finally , could pave way investigation , notably field cognitive impairment prevention , aim reduce delay onset dementia act `` vascular factor '' , potentially modifiable .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>patient participate Adelahyde 1 study patient sign consent patient social security patient ca n't understand information letter legal protection</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Cognitive function</keyword>
</DOC>